John Stuelpnagel

Chairman at 10X GENOMICS, INC.

Net worth: 95 M $ as of 2026-06-29

68 year

83 connections

Health Technology

Finance

Consumer Services

Profile

John R. Stuelpnagel is an entrepreneur and businessperson who founded Illumina, Inc., Fabric Genomics, Inc. and Ariosa Diagnostics, Inc. and who has been the head of 6 different companies. He is Chairman for 10X Genomics, Inc., Chairman at Fabric Genomics, Inc., Chairman for Inscripta, Inc. and Chairman for Element Biosciences, Inc. John R. Stuelpnagel is also on the board of Federation Bio, Inc. and Encoded Therapeutics, Inc. In the past Dr. Stuelpnagel held the position of Chief Operating Officer & Director at Illumina, Inc., Associate at CW Group, Inc., BRD at Sequenta, Inc. and Executive Chairman of Ariosa Diagnostics, Inc. He received a doctorate and an undergraduate degree from the University of California, Davis and an MBA from the University of California, Los Angeles.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
10X GENOMICS INC 10.47%	2026-03-30	2,105,736 ( 10.47% )	81 M $	2026-06-29
10X GENOMICS INC CLASS A 0.32%	2026-06-03	369,607 ( 0.32% )	14 M $	2026-06-29

John Stuelpnagel active positions

Companies	Position	Start
10X GENOMICS, INC.	Chairman	2013-07-31
Fabric Genomics, Inc. Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform	Founder	-
Inscripta, Inc. Inscripta, Inc. BiotechnologyHealth Technology Develops digital genome engineering solutions	Chairman	2017-03-31
Encoded Therapeutics, Inc. Encoded Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a clinical-stage biotechnology company that develops and manufactures disease-modifying gene therapies for pediatric central nervous system	Director/Board Member	2017-04-30
Federation Bio, Inc. Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics	Director/Board Member	2020-05-31
Venrock Associates Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions.	Consultant / Advisor	1997-12-31

All active positions of John Stuelpnagel

Former positions of John Stuelpnagel

Companies	Position	End
Element Biosciences, Inc. Element Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and sells DNA sequencing instruments and chemistry & multi omics platforms	Chairman	2022-12-31
ADAPTIVE BIOTECHNOLOGIES CORPORATION	Director/Board Member	2017-10-31
Ariosa Diagnostics, Inc. Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services	Founder	2014-12-31
░░░░░░░░░ ░░░░	░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░

See the detail of John Stuelpnagel's experience

Training of John Stuelpnagel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Stuelpnagel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Venrock Associates Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions.	Finance
Illumina, Inc. Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments	Health Technology
Sequenta, Inc. Sequenta, Inc. BiotechnologyHealth Technology Operates as a biotech company which discovers and develops clinical diagnostics based on immune system status	Health Technology
10X Genomics, Inc. 10X Genomics, Inc. BiotechnologyHealth Technology Develops integrated systems and solutions for genome sequencing, exome sequencing and single cell transcriptomics	Health Technology
CW Group, Inc. CW Group, Inc. Investment ManagersFinance CW Group invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements.	Finance
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Davis University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fabric Genomics, Inc. Fabric Genomics, Inc. Packaged SoftwareTechnology Services Develops AI-powered genomic interpretation platform	Technology Services
Ariosa Diagnostics, Inc. Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Offers diagnostics and genetic testing services	Health Services
Adaptive Biotechnologies Corp. Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine	Health Technology
Inscripta, Inc. Inscripta, Inc. BiotechnologyHealth Technology Develops digital genome engineering solutions	Health Technology
Federation Bio, Inc. Federation Bio, Inc. BiotechnologyHealth Technology Research and develops micro biome therapeutics	Health Technology
Element Biosciences, Inc. Element Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and sells DNA sequencing instruments and chemistry & multi omics platforms	Health Technology
Encoded Therapeutics, Inc. Encoded Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a clinical-stage biotechnology company that develops and manufactures disease-modifying gene therapies for pediatric central nervous system	Health Technology